Cancer Genetics and Epigenetics 2024, Vol.12, No.6, 317-328 http://medscipublisher.com/index.php/cge 326 Heide T., Househam J., Cresswell G.D., Spiteri I., Lynn C., Mossner M., Kimberley C., Fernández-Mateos J., Chen B., Zapata L., James C., Barozzi I., Chkhaidze K., Nichol D., Berner A., Schmidt M., Lakatos E., Baker A., Costa H., Mitchinson M., Jansen M., Caravagna G., Ramazzotti D., Shibata D., Bridgewater J., Rodríguez-Justo M., Magnani L., Graham T.A., and Sottoriva A., 2021, The co-evolution of the genome and epigenome in colorectal cancer, Nature, 611: 733-743. https://doi.org/10.1038/s41586-022-05202-1 PMID: 36289335 PMCID: PMC9684080 Huang D.D., Sun W.J., Zhou Y.W., Li P.W., Chen F., Chen H.W., Xia D.J., Xu E.P., Lai M.D., Wu Y.H., and Zhang H.H., 2018, Mutations of key driver genes in colorectal cancer progression and metastasis, Cancer and Metastasis Reviews, 37(1): 173-187. https://doi.org/10.1007/s10555-017-9726-5 PMID: 29322354 Johnson H., El-Schich Z., Ali A., Zhang X.H., Simoulis A., Wingren A.G., and Persson J.L., 2022, Gene-mutation-based algorithm for prediction of treatment response in colorectal cancer patients, Cancers, 14(8): 2045. https://doi.org/10.3390/cancers14082045 PMID: 35454952 PMCID: PMC9030299 Kastrinos F., Samadder N.J., and Burt R.W., 2019, Use of family history and genetic testing to determine risk of colorectal cancer, Gastroenterology, 158(2): 389-403. https://doi.org/10.1053/j.gastro.2019.11.029 PMID: 31759928 Kato S., Schwaederlé M.C., Fanta P.T., Okamura R., Leichman L., Lippman S.M., Lanman R.B., Raymond V.M., Talasaz A., and Kurzrock R., 2019, Genomic assessment of blood-derived circulating tumor DNA in patients with colorectal cancers: correlation with tissue sequencing, Therapeutic Response, and Survival, JCO Precision Oncology, 3: PO.18.00158. https://doi.org/10.1200/PO.18.00158 Kim J.E., Chun S.M., Hong Y.S., Kim K.P., Kim S.Y., Kim J., Sung C.O., Cho E.J., Kim T.W., and Jang S.J., 2019, Mutation burden and I index for detection of microsatellite instability in colorectal cancer by targeted next-generation sequencing, The Journal of Molecular Diagnostics, 21(2): 241-250. https://doi.org/10.1016/j.jmoldx.2018.09.005 PMID: 30389464 Kyrochristos I.D., Ziogas D.E., Goussia A., Glantzounis G.K., and Roukos D.H., 2019, Bulk and single-cell next-generation sequencing: individualizing treatment for colorectal cancer, Cancers, 11(11): 1809. https://doi.org/10.3390/cancers11111809 PMID: 31752125 PMCID: PMC6895993 Lee C.S., Song I.H., Lee A., Kang J., Lee Y.S., Lee I.K., Song Y.S., and Lee S.H., 2020, Enhancing the landscape of colorectal cancer using targeted deep sequencing, Scientific Reports, 11(1): 8154. https://doi.org/10.1038/s41598-021-87486-3 PMID: 33854094 PMCID: PMC8046812 Li L.L., Hu Y.L., Xu Y.S., and Tang SY.., 2023, Mathematical modeling the order of driver gene mutations in colorectal cancer, PLOS Computational Biology, 19(6): e1011225. https://doi.org/10.1371/journal.pcbi.1011225 PMID: 37368936 PMCID: PMC10332632 Li W.H., Qiu T., Guo L., Ying J.M., and Zhou A.P., 2019, NGS-based oncogenic mutations analysis in advanced colorectal cancer patients improves targeted therapy prediction, Pathology, Research and Practice, 215(3): 483-489. https://doi.org/10.1016/j.prp.2018.12.037 PMID: 30611619 Liebs S., Keilholz U., Kehler I., Schweiger C., Haybäck J., and Nonnenmacher A., 2019, Detection of mutations in circulating cell-free DNA in relation to disease stage in colorectal cancer, Cancer Medicine, 8(8): 3761-3769. https://doi.org/10.1002/cam4.2219 Lorans M., Dow E., Macrae F., Winship I.M., and Buchanan D.D., 2018, Update on hereditary colorectal cancer: improving the clinical utility of multigene panel testing, Clinical Colorectal Cancer, 17(2): e293-e305. https://doi.org/10.1016/j.clcc.2018.01.001 PMID: 29454559 Marbun V.M.G., Erlina L., and Lalisang T.J.M., 2022, Genomic landscape of pathogenic mutation of APC, KRAS, TP53, PIK3CA, and MLH1 in Indonesian colorectal cancer, PLoS One, 17(6): e0267090. https://doi.org/10.1371/journal.pone.0267090 PMID: 35709138 PMCID: PMC9202917 Messaritakis I., Psaroudaki E., Vogiatzoglou K., Sfakianaki M., Topalis P., Iliopoulos I., Mavroudis D., Tsiaoussis J., Gouvas N., Tzardi M., and Souglakos J., 2023, Unraveling the role of molecular profiling in predicting treatment response in stage III colorectal cancer patients: insights from the IDEA international study, Cancers, 15(19): 4819. https://doi.org/10.3390/cancers15194819 PMID: 37835512 PMCID: PMC10571744
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==